GlaxoSmithKline competitorsClear all
GlaxoSmithKline's top competitors include Bayer, Novartis, Merck, Pfizer, Eli Lilly, AstraZeneca and Takeda Pharmaceutical.
| Save Comparison |  Novartis Novartis is a company that researches, develops, manufactures, and markets a range of healthcare products. |  Pfizer Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products. |  Eli Lilly Eli Lilly and Company is engaged in the discovery, development, manufacture, and sale of products in the pharmaceutical business segment. |  AstraZeneca AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ||||
Founding Date | Founding Date 2000 | Founding Date 1863 | Founding Date 1996 | Founding Date 1891 | Founding Date 1849 | Founding Date 1876 | Founding Date 1999 | Founding Date 1781 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||||
Locations | Locations Brentford, GB HQ Tiranë, AL Boudouaou, DZ Victoria, AR Abbotsford, AU Boronia, AU Wien, AT see more | Locations Kenilworth, US HQ Buenos Aires, AR Adelaide, AU Brisbane, AU Canberra, AU Perth, AU Sydney, AU see more | Locations Indianapolis, US HQ Sydney, AU Melrose Park, AU Wien, AT Charlottetown, CA Toronto, CA Baoding, CN see more | Locations Cambridge, GB HQ Algiers, DZ Tizi Ouzou, DZ Buenos Aires, AR Haedo, AR Macquarie Park, AU Macquarie Park, AU see more | Locations Chuo City, JP HQ Sydney, AU Linz, AT Sint Jans Molenbeek, BE Santo Amaro, BR Oakville, CA Shanghai, CN see more | |||
Employees | Employees 95,4903% decrease | Employees 103,8241% decrease | Employees 103,91417% decrease | Employees 71,0003% increase | Employees 88,3004% decrease | Employees 33,62513% decrease | Employees 70,600 | Employees 49,57882% increase |
Valuation ($) | Valuation ($) 103.3 b | Valuation ($) 66.7 b | Valuation ($) N/A | Valuation ($) 203.7 b | Valuation ($) 212.1 b | Valuation ($) 146.3 b | Valuation ($) 142.4 b | Valuation ($) 60.6 b |
Twitter followers | Twitter followers 197.9 k | Twitter followers 173.4 k | Twitter followers 268.7 k | Twitter followers 186.7 k | Twitter followers 18.3 k | Twitter followers 69 | Twitter followers 177.3 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 81 | Number of tweets (last 30 days) 58 | Number of tweets (last 30 days) 31 | Number of tweets (last 30 days) 53 | Number of tweets (last 30 days) 4 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 31 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 24.2 | Average likes per tweet (last 30 days) 10.6 | Average likes per tweet (last 30 days) 14.3 | Average likes per tweet (last 30 days) 25.5 | Average likes per tweet (last 30 days) 11.3 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 43.4 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 82.72% | Percentage of tweets with engagement (last 30 days) 65.52% | Percentage of tweets with engagement (last 30 days) 64.52% | Percentage of tweets with engagement (last 30 days) 98.11% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 55980 | Alexa Website Rank 94682 | Alexa Website Rank 89332 | Alexa Website Rank 100197 | Alexa Website Rank 33553 | Alexa Website Rank 166332 | Alexa Website Rank 117937 | Alexa Website Rank 544088 |
Employee Rating | Employee Rating 3.9 | Employee Rating N/A | Employee Rating 3.9 | Employee Rating 3.9 | Employee Rating 4.0 | Employee Rating 3.6 | Employee Rating 3.9 | Employee Rating N/A |
Financial | ||||||||
Revenue (est.) | Revenue (est.) £30.8b (FY, 2018) | Revenue (est.) €43.5b (FY, 2019) | Revenue (est.) $49.1b (FY, 2017) | Revenue (est.) $46.8b (FY, 2019) | Revenue (est.) $51.8b (FY, 2019) | Revenue (est.) $22.3b (FY, 2019) | Revenue (est.) $24.4b (FY, 2019) | Revenue (est.) $1.8b (Y, 2015) |
Cost of goods | Cost of goods £10.2b (FY, 2018) | Cost of goods €17.5b (FY, 2019) | Cost of goods $17.2b (FY, 2017) | Cost of goods $14.1b (FY, 2019) | Cost of goods $10.2b (FY, 2019) | Cost of goods $4.7b (FY, 2019) | Cost of goods $4.9b (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit £20.6b (FY, 2018) | Gross profit €26.1b (FY, 2019) | Gross profit $31.9b (FY, 2017) | Gross profit $32.7b (FY, 2019) | Gross profit $41.5b (FY, 2019) | Gross profit $17.6b (FY, 2019) | Gross profit $19.5b (FY, 2019) | Gross profit N/A |
Net income | Net income £4b (FY, 2018) | Net income €2.4b (FY, 2019) | Net income $7.7b (FY, 2017) | Net income $9.8b (FY, 2019) | Net income $16.3b (FY, 2019) | Net income $8.3b (FY, 2019) | Net income $1.2b (FY, 2019) | Net income $83.5 (Y, 2015) |
Operating ⚠ | ||||||||
Countries | Countries 100 (FY, 2018) | Countries 153 (FY, 2018) | Countries N/A | Countries N/A | Countries 125 (FY, 2017) | Countries N/A | Countries 100 (FY, 2019) | Countries N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 12 (Jan, 2020) | Phase II Trials Products N/A | Phase II Trials Products 19 (Apr, 2020) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 9 (Jan, 2020) | Phase III Trials Products 37 (FY, 2017) | Phase III Trials Products 24 (Apr, 2020) | Phase III Trials Products 29 (FY, 2017) | Phase III Trials Products 19 (FY, 2016) | Phase III Trials Products N/A | Phase III Trials Products N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 10 (May, 2018) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 66 (FY, 2016) | Projects in R&D Pipeline 167 (FY, 2019) | Projects in R&D Pipeline N/A |
Funding | ||||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised $ 5m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 57.8m |
For sources of this data, please see the company profile
View company profiles
Bayer
HQ
Leverkusen, DE
Employees
103,824↓ 1% decrease
Bayer is a global life science company specializing in healthcare and nutrition.
View companyNovartis
HQ
Basel, CH
Employees
103,914↓ 17% decrease
Novartis is a company that researches, develops, manufactures, and markets a range of healthcare products.
View company
Merck
HQ
Kenilworth, US
Employees
71,000↑ 3% increase
Merck is a healthcare manufacturer and distributor of pharmaceuticals.
View companyPfizer
HQ
New York, US
Employees
88,300↓ 4% decrease
Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
View company